Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Boucheix, C; Rubinstein, E
   Tetraspanins
   CELLULAR AND MOLECULAR LIFE SCIENCES
   
   C. Boucheix e E. Rubinstein, "Tetraspanins", CELL MOL L, 58(9), 2001, pp. 1189-1205
2. Cascales, E; Lioubes, R; Sturgis, JN
   The ToIQ-ToIR proteins energize ToIA and share homologies with the flagellar motor proteins MotA-MotB
   MOLECULAR MICROBIOLOGY
   
   E. Cascales et al., "The ToIQ-ToIR proteins energize ToIA and share homologies with the flagellar motor proteins MotA-MotB", MOL MICROB, 42(3), 2001, pp. 795-807
3. Larsen, RA; Postle, K
   Conserved residues Ser(16) and His(20) and their relative positioning are essential for TonB activity, cross-linking of TonB with ExbB, and the ability of TonB to respond to proton motive force
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   R.A. Larsen e K. Postle, "Conserved residues Ser(16) and His(20) and their relative positioning are essential for TonB activity, cross-linking of TonB with ExbB, and the ability of TonB to respond to proton motive force", J BIOL CHEM, 276(11), 2001, pp. 8111-8117
4. de Fougerolles, AR; Batista, F; Johnsson, E; Fearon, DT
   IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19
   EUROPEAN JOURNAL OF IMMUNOLOGY
   
   A.R. de Fougerolles et al., "IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19", EUR J IMMUN, 31(7), 2001, pp. 2189-2199
5. Ikemoto, T; Nakagawa, T; Hatanaka, M; Hasegawa, M; Kageyama, T; Hirano, M; Shimizu, A
   My4(+)/LeuM3(-) molecule and CD19 antigen are down-modulate by low affinity Fc gamma receptor II (CD32) stimulation on CD56-positive B-lymphoma cells
   LEUKEMIA & LYMPHOMA
   
   T. Ikemoto et al., "My4(+)/LeuM3(-) molecule and CD19 antigen are down-modulate by low affinity Fc gamma receptor II (CD32) stimulation on CD56-positive B-lymphoma cells", LEUK LYMPH, 39(1-2), 2000, pp. 157-164
6. Tolnay, M; Tsokos, GC
   Serum regulates the expression of complement receptor 2 on human B cell lines.
   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
   
   M. Tolnay e G.C. Tsokos, "Serum regulates the expression of complement receptor 2 on human B cell lines.", IMMUNOPH IM, 22(2), 2000, pp. 205-219
7. Smith, KGC; Fearon, DT
   Receptor modulators of B-cell receptor signalling - CD19/CD22
   SIGNAL TRANSDUCTION AND THE COORDINATION OF B LYMPHOCYTE DEVELOPMENT AND FUNCTION I
   
   K.G.C. Smith e D.T. Fearon, "Receptor modulators of B-cell receptor signalling - CD19/CD22", CURR T MICR, 245, 2000, pp. 195-212
8. Marchbank, KJ; Watson, CC; Ritsema, DF; Holers, VM
   Expression of human complement receptor 2 (CR2, CD21) in Cr2(-/-) mice restores humoral immune function
   JOURNAL OF IMMUNOLOGY
   
   K.J. Marchbank et al., "Expression of human complement receptor 2 (CR2, CD21) in Cr2(-/-) mice restores humoral immune function", J IMMUNOL, 165(5), 2000, pp. 2354-2361
9. Toyo-oka, K; Yashiro-Ohtani, Y; Park, CS; Tai, XG; Miyake, K; Hamaoka, T; Fujiwara, H
   Association of a tetraspanin CD9 with CD5 on the T cell surface: role of particular transmembrane domains in the association
   INTERNATIONAL IMMUNOLOGY
   
   K. Toyo-oka et al., "Association of a tetraspanin CD9 with CD5 on the T cell surface: role of particular transmembrane domains in the association", INT IMMUNOL, 11(12), 1999, pp. 2043-2052
10. Villiers, MB; Villiers, CL; Laharie, AM; Marche, PN
    Different stimulating effects of complement C3b and complete Freund's adjuvant on antibody response
    IMMUNOPHARMACOLOGY
    
    M.B. Villiers et al., "Different stimulating effects of complement C3b and complete Freund's adjuvant on antibody response", IMMUNOPHARM, 42(1-3), 1999, pp. 151-157
11. Villiers, MB; Villiers, CL; Laharie, AM; Marche, PN
    Amplification of the antibody response by C3b complexed to antigen throughan ester link
    JOURNAL OF IMMUNOLOGY
    
    M.B. Villiers et al., "Amplification of the antibody response by C3b complexed to antigen throughan ester link", J IMMUNOL, 162(6), 1999, pp. 3647-3652
12. FUJIMOTO M; POE JC; INAOKI M; TEDDER TF
    CD19 REGULATES B-LYMPHOCYTE RESPONSES TO TRANSMEMBRANE SIGNALS
    Seminars in immunology
    
    M. Fujimoto et al., "CD19 REGULATES B-LYMPHOCYTE RESPONSES TO TRANSMEMBRANE SIGNALS", Seminars in immunology, 10(4), 1998, pp. 267-277
13. JURLANDER J
    THE CELLULAR BIOLOGY OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    Critical reviews in oncology/hematology
    
    J. Jurlander, "THE CELLULAR BIOLOGY OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA", Critical reviews in oncology/hematology, 27(1), 1998, pp. 29-52
14. MIYAZAKI T; MULLER U; CAMPBELL KS
    NORMAL DEVELOPMENT BUT DIFFERENTIALLY ALTERED PROLIFERATIVE RESPONSESOF LYMPHOCYTES IN MICE LACKING CD81
    EMBO journal
    
    T. Miyazaki et al., "NORMAL DEVELOPMENT BUT DIFFERENTIALLY ALTERED PROLIFERATIVE RESPONSESOF LYMPHOCYTES IN MICE LACKING CD81", EMBO journal, 16(14), 1997, pp. 4217-4225
15. 
    B-CELLS
    Immunology today
    
    Immunology today, 1997, pp. 1-8
16. SATO S; MILLER AS; HOWARD MC; TEDDER TF
    REGULATION OF B-LYMPHOCYTE DEVELOPMENT AND ACTIVATION BY THE CD19 CD21/CD81/LEU-13 COMPLEX REQUIRES THE CYTOPLASMIC DOMAIN OF CD19/
    The Journal of immunology
    
    S. Sato et al., "REGULATION OF B-LYMPHOCYTE DEVELOPMENT AND ACTIVATION BY THE CD19 CD21/CD81/LEU-13 COMPLEX REQUIRES THE CYTOPLASMIC DOMAIN OF CD19/", The Journal of immunology, 159(7), 1997, pp. 3278-3287
17. TAKAHASHI K; KOZONO Y; WALDSCHMIDT TJ; BERTHIAUME D; QUIGG RJ; BARON A; HOLERS VM
    MOUSE COMPLEMENT RECEPTORS TYPE-1 (CR-1, CD35) AND TYPE-2 (CR-2, CD21) - EXPRESSION ON NORMAL B-CELL SUBPOPULATIONS AND DECREASED LEVELS DURING THE DEVELOPMENT OF AUTOIMMUNITY IN MRL LPR MICE/
    The Journal of immunology
    
    K. Takahashi et al., "MOUSE COMPLEMENT RECEPTORS TYPE-1 (CR-1, CD35) AND TYPE-2 (CR-2, CD21) - EXPRESSION ON NORMAL B-CELL SUBPOPULATIONS AND DECREASED LEVELS DURING THE DEVELOPMENT OF AUTOIMMUNITY IN MRL LPR MICE/", The Journal of immunology, 159(3), 1997, pp. 1557-1569
18. 
    B-CELLS
    Immunology today
    
    Immunology today, 1996, pp. 8-14
19. LEE YJ; LUISIRI P; CLARK MR
    NOVEL COMPLEX, P40 42, IS CONSTITUTIVELY ASSOCIATED WITH THE B-CELL ANTIGEN RECEPTOR AND PHOSPHORYLATED UPON RECEPTOR STIMULATION/
    The Journal of immunology
    
    Y.J. Lee et al., "NOVEL COMPLEX, P40 42, IS CONSTITUTIVELY ASSOCIATED WITH THE B-CELL ANTIGEN RECEPTOR AND PHOSPHORYLATED UPON RECEPTOR STIMULATION/", The Journal of immunology, 157(9), 1996, pp. 3828-3837
20. KROP I; SHAFFER AL; FEARON DT; SCHLISSEL MS
    THE SIGNALING ACTIVITY OF MURINE CD19 IS REGULATED DURING B-CELL DEVELOPMENT
    The Journal of immunology
    
    I. Krop et al., "THE SIGNALING ACTIVITY OF MURINE CD19 IS REGULATED DURING B-CELL DEVELOPMENT", The Journal of immunology, 157(1), 1996, pp. 48-56
21. PRODINGER WM; LARCHER C; SCHWENDINGER M; DIERICH MP
    LIGATION OF THE FUNCTIONAL DOMAIN OF COMPLEMENT RECEPTOR-TYPE-2 (CR-2, CD21) IS RELEVANT FOR COMPLEX-FORMATION IN T-CELL LINES
    The Journal of immunology
    
    W.M. Prodinger et al., "LIGATION OF THE FUNCTIONAL DOMAIN OF COMPLEMENT RECEPTOR-TYPE-2 (CR-2, CD21) IS RELEVANT FOR COMPLEX-FORMATION IN T-CELL LINES", The Journal of immunology, 156(7), 1996, pp. 2580-2584
22. LANKESTER AC; ROOD PML; VANSCHIJNDEL GMW; HOOIBRINK B; VERHOEVEN AJ; VANLIER RAW
    ALTERATION OF B-CELL ANTIGEN RECEPTOR SIGNALING BY CD19 CO-LIGATION -A STUDY WITH BISPECIFIC ANTIBODIES
    The Journal of biological chemistry
    
    A.C. Lankester et al., "ALTERATION OF B-CELL ANTIGEN RECEPTOR SIGNALING BY CD19 CO-LIGATION -A STUDY WITH BISPECIFIC ANTIBODIES", The Journal of biological chemistry, 271(37), 1996, pp. 22326-22330
23. FEARON DT
    THE B-LYMPHOCYTE AS AN IMMUNOTHERAPEUTIC TARGET
    Quarterly Journal of Medicine
    
    D.T. Fearon, "THE B-LYMPHOCYTE AS AN IMMUNOTHERAPEUTIC TARGET", Quarterly Journal of Medicine, 88(3), 1995, pp. 149-153
24. FEARON DT; CARTER RH
    THE CD19 CR2/TAPA-1 COMPLEX OF B-LYMPHOCYTES - LINKING NATURAL TO ACQUIRED-IMMUNITY/
    Annual review of immunology
    
    D.T. Fearon e R.H. Carter, "THE CD19 CR2/TAPA-1 COMPLEX OF B-LYMPHOCYTES - LINKING NATURAL TO ACQUIRED-IMMUNITY/", Annual review of immunology, 13, 1995, pp. 127-149
25. UCKUN FM; EVANS WE; FORSYTH CJ; WADDICK KG; AHLGREN LT; CHELSTROM LM; BURKHARDT A; BOLEN J; MYERS DE
    BIOTHERAPY OF B-CELL PRECURSOR LEUKEMIA BY TARGETING GENISTEIN TO CD19-ASSOCIATED TYROSINE KINASES
    Science
    
    F.M. Uckun et al., "BIOTHERAPY OF B-CELL PRECURSOR LEUKEMIA BY TARGETING GENISTEIN TO CD19-ASSOCIATED TYROSINE KINASES", Science, 267(5199), 1995, pp. 886-891
26. BOUILLIE S; BAREL M; DRANE P; CASSINAT B; BALBO M; HOLERS VM; FRADE R
    EPSTEIN-BARR-VIRUS C3D RECEPTOR (CR2, CD21) ACTIVATED BY ITS EXTRACELLULAR LIGANDS REGULATES PP105 PHOSPHORYLATION THROUGH 2 DISTINCT PATHWAYS
    European Journal of Immunology
    
    S. Bouillie et al., "EPSTEIN-BARR-VIRUS C3D RECEPTOR (CR2, CD21) ACTIVATED BY ITS EXTRACELLULAR LIGANDS REGULATES PP105 PHOSPHORYLATION THROUGH 2 DISTINCT PATHWAYS", European Journal of Immunology, 25(9), 1995, pp. 2661-2667